UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
+$957M |
| 2 |
Microsoft
MSFT
|
+$866M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$692M |
| 4 |
NVIDIA
NVDA
|
+$639M |
| 5 |
Alibaba
BABA
|
+$522M |
Top Sells
| 1 |
Apple
AAPL
|
+$20.3B |
| 2 |
Amazon
AMZN
|
+$10.9B |
| 3 |
Bank of America
BAC
|
+$1.64B |
| 4 |
Applied Materials
AMAT
|
+$1.09B |
| 5 |
Prologis
PLD
|
+$1.03B |
Sector Composition
| 1 | Technology | 29.67% |
| 2 | Financials | 14.84% |
| 3 | Healthcare | 13.16% |
| 4 | Communication Services | 8.88% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
PBF Energy
PBF
$3.18B
| $5M | ﹤0.01% |
261,704
+12,289
| +5% | +$235K |
|
1577
Arbe Robotics
ARBE
$146M
| $4.99M | ﹤0.01% |
4,849,154
+3,162,282
| +187% | +$3.26M |
|
1578
CONMED
CNMD
$1.64B
| $4.99M | ﹤0.01% |
82,686
+4,565
| +6% | +$276K |
|
|
AMTM
1579
Amentum Holdings, Inc.
AMTM
$5.8B
| $4.97M | ﹤0.01% |
273,283
-451
| -0.2% | -$8.21K |
|
1580
Phillips Edison & Co
PECO
$4.47B
| $4.97M | ﹤0.01% |
136,108
-649,820
| -83% | -$23.7M |
|
1581
IDEAYA Biosciences
IDYA
$2.16B
| $4.97M | ﹤0.01% |
303,145
-20,141
| -6% | -$330K |
|
1582
Evolent Health
EVH
$1.05B
| $4.95M | ﹤0.01% |
522,956
-343,545
| -40% | -$3.25M |
|
1583
Bank of Hawaii
BOH
$2.7B
| $4.95M | ﹤0.01% |
71,779
-173,716
| -71% | -$12M |
|
1584
Carter's
CRI
$1.08B
| $4.95M | ﹤0.01% |
120,964
+6,195
| +5% | +$253K |
|
1585
Vertex
VERX
$3.84B
| $4.94M | ﹤0.01% |
141,206
-24,315
| -15% | -$851K |
|
1586
Lindsay Corp
LNN
$1.52B
| $4.94M | ﹤0.01% |
39,056
+2,811
| +8% | +$356K |
|
1587
United Natural Foods
UNFI
$1.77B
| $4.94M | ﹤0.01% |
180,246
-8,396
| -4% | -$230K |
|
1588
Avis
CAR
$5.47B
| $4.94M | ﹤0.01% |
65,023
+9,246
| +17% | +$702K |
|
1589
FormFactor
FORM
$2.32B
| $4.92M | ﹤0.01% |
173,979
+9,394
| +6% | +$266K |
|
1590
Quaker Houghton
KWR
$2.46B
| $4.91M | ﹤0.01% |
39,723
-6,877
| -15% | -$850K |
|
1591
Freedom Holding
FRHC
$10.1B
| $4.9M | ﹤0.01% |
37,068
+3,771
| +11% | +$498K |
|
1592
Clarivate
CLVT
$2.88B
| $4.89M | ﹤0.01% |
1,243,683
+144,462
| +13% | +$568K |
|
1593
Dana Inc
DAN
$2.76B
| $4.89M | ﹤0.01% |
366,643
+12,933
| +4% | +$172K |
|
1594
Leonardo DRS
DRS
$11.2B
| $4.88M | ﹤0.01% |
148,474
+12,712
| +9% | +$418K |
|
1595
Apellis Pharmaceuticals
APLS
$3.14B
| $4.87M | ﹤0.01% |
222,634
+9,747
| +5% | +$213K |
|
1596
OR Royalties Inc.
OR
$6.76B
| $4.87M | ﹤0.01% |
230,511
-347,894
| -60% | -$7.35M |
|
1597
iQIYI
IQ
$2.51B
| $4.86M | ﹤0.01% |
2,152,263
+1,716,011
| +393% | +$3.88M |
|
1598
Powell Industries
POWL
$3.47B
| $4.84M | ﹤0.01% |
28,423
+1,311
| +5% | +$223K |
|
1599
First Busey Corp
BUSE
$2.19B
| $4.8M | ﹤0.01% |
222,048
+97,560
| +78% | +$2.11M |
|
1600
Disc Medicine
IRON
$2.08B
| $4.79M | ﹤0.01% |
96,557
+3,454
| +4% | +$171K |
|